BridgeBio have significantly boosted the progress of a new treatment for amyloid heart disease, leveraging the investigational drug. Initial patient information suggests promising outcomes for individuals affected from https://bridgebio798141.blogtov.com/22832437/bridgebio-improves-cardiac-amyloidosis-management-through-the-drug